SCHEMBL6136982

SCHEMBL6136982

CCOC(=O)c1cc(C)cc(C)c1N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.59
ALDH1A1 P00352 8/20 0.50
HSD17B10 Q99714 5/20 0.50
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2C19 P33261 1/20 0.49
GAA P10253 5/20 0.49
MAPK1 P28482 1/20 0.49
TSHR P16473 1/20 0.48
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
LMNA P02545 3/20 0.44
MAOA P21397 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15214246 0.84 CA12 (0.56) KDM4EALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL17955668 0.84 CA12 (0.53) KDM4EALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL16529438 0.83 ALDH1A1 (0.55) KDM4EALDH1A1HSD17B10GAAMAPK1
SCHEMBL12326380 0.83 ALDH1A1 (0.47) KDM4EALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL5809914 0.83 ALDH1A1 (0.47) KDM4EALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL2821342 0.83 ALDH1A1 (0.47) KDM4EALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL5094601 0.81 KDM4E (0.63) KDM4EALDH1A1HSD17B10GAATSHR
SCHEMBL20234069 0.81 TSHR (0.52) KDM4EALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL24371499 0.81 CA1 (0.48) KDM4EALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL29598886 0.81 CA1 (0.48) KDM4EALDH1A1HSD17B10CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1029851-B1 PIPERAZINE COMPOUNDS AND MEDICINAL USE THEREOF MITSUBISHI PHARMA CORP (JP) 2005-04-20 EP disclosed
US-6455528-B1 TUMOR NECROSIS FACTOR ANTAGONIST AND/OR INTERLEUKIN PROMOTER; ANTIALLERGENS, ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE TREATMENT MITSUBISHI PHARMA CORPORATION (JP) 2002-09-24 US disclosed
EP-0805812-B1 BICYCLIC SUBSTITUTED HEXAHYDROBENZ(E)ISOINDOLE ALPHA-1- ADRENERGIC ANTAGONISTS ABBOTT LAB (US) 2001-06-13 EP disclosed
US-5792767-A TREATMENT OF BENIGN PROSTATIC HYPERTROPY ABBOTT LABORATORIES (US) 1998-08-11 US disclosed
US-5521181-A Bicyclic substituted hexahydrobenz[e]isoindole α-1 adrenergic antagonists ABBOTT LABORATORIES (US) 1996-05-28 US disclosed